$ cat ./records/bill-gates-opposes-waiving-covid-19-vaccine-patents-then-the-foun-2021.txt
Bill Gates Opposes Waiving COVID-19 Vaccine Patents, Then the Foundation Reverses Course
[RECORD.TXT] · cat --full
In an interview published in late April 2021, Bill Gates opposed a proposal by India and South Africa — backed by more than 100 countries — to waive World Trade Organization (TRIPS) intellectual-property protections on COVID-19 vaccines, arguing that patents were not the bottleneck and that vaccine recipes could not simply be handed to new factories without risk. Gates lobbied US Trade Representative Katherine Tai to preserve the protections, but on May 5, 2021 the Biden administration announced it would support a waiver. Global-health advocates accused Gates of impeding equitable vaccine access; within days the Gates Foundation publicly softened its stance and said it backed a narrow waiver. The episode became a focal point in debates over the influence of private philanthropy on global health policy.
Source: https://www.devex.com/news/gates-foundation-reverses-course-on-covid-19-vaccine-patents-99810
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
New York Times Reports Misconduct Allegations Against Gates's Money Manager Michael Larson
Next →
Microsoft Board Investigated Bill Gates's Relationship With an Employee Before His 2020 Board Exit
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.